lobbying_filings_raw: 219573b3-376d-4eef-aee0-248d6062514c

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API. Sortable columns (indexed): filing_type, client_name, filing_year, client_state, registrant_state, registrant_house_id, registrant_id. Sorting on any other column returns HTTP 400 (2026-09-04, #697) — use ?sql= with your own ORDER BY if you need it.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence income_amount expense_amount
219573b3-376d-4eef-aee0-248d6062514c Q2 20744 TIBER CREEK GROUP 127120 PHRMA 2021 second_quarter 2021-07-17T11:48:46.400000-04:00 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/219573b3-376d-4eef-aee0-248d6062514c/", "filing_uuid": "219573b3-376d-4eef-aee0-248d6062514c", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2021, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/219573b3-376d-4eef-aee0-248d6062514c/print/", "filing_document_content_type": "text/html", "income": "110000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Jonathon Jones, Partner", "dt_posted": "2021-07-17T11:48:46.400000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1300 CONNECTICUT AVENUE, NW", "registrant_address_2": "SIXTH FLOOR", "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20036", "registrant": {"id": 20744, "url": "https://lda.senate.gov/api/v1/registrants/20744/", "house_registrant_id": 31587, "name": "TIBER CREEK GROUP", "description": "Government Relations.", "address_1": "750 9th Street NW", "address_2": "Suite 501", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20001", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "GRACE BAUM", "contact_telephone": "+1 202-381-6896", "dt_updated": "2026-01-28T11:50:36.069441-05:00"}, "client": {"id": 127120, "url": "https://lda.senate.gov/api/v1/clients/127120/", "client_id": 1001821, "name": "PHRMA", "general_description": null, "client_government_entity": false, "client_self_select": null, "state": null, "state_display": null, "country": "", "country_display": "* Undetermined", "ppb_state": null, "ppb_state_display": null, "ppb_country": "", "ppb_country_display": "* Undetermined", "effective_date": "2007-07-27"}, "lobbying_activities": [{"general_issue_code": "TRD", "general_issue_code_display": "Trade (domestic/foreign)", "description": "Issues relating to Intellectual Property protections for Covid-19 treatments and vaccines.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 47178, "prefix": null, "prefix_display": null, "first_name": "JOHN", "nickname": null, "middle_name": "MICHAEL", "last_name": "GONZALEZ", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 26450, "prefix": null, "prefix_display": null, "first_name": "JONATHON", "nickname": null, "middle_name": null, "last_name": "JONES", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "S. 1435 - Affordable Prescriptions for Patients Act of 2021; H.R. 2873 - Affordable Prescriptions for Patients Through Promoting Competition Act of 2021", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 26450, "prefix": null, "prefix_display": null, "first_name": "JONATHON", "nickname": null, "middle_name": null, "last_name": "JONES", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 47178, "prefix": null, "prefix_display": null, "first_name": "JOHN", "nickname": null, "middle_name": "MICHAEL", "last_name": "GONZALEZ", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Issues related to drug pricing, reimbursement for prescription drugs, and the pharmaceutical supply chain; Issues related to capping out of pocket costs.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 26450, "prefix": null, "prefix_display": null, "first_name": "JONATHON", "nickname": null, "middle_name": null, "last_name": "JONES", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 47178, "prefix": null, "prefix_display": null, "first_name": "JOHN", "nickname": null, "middle_name": "MICHAEL", "last_name": "GONZALEZ", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Issues related to Medicare Part B pricing reform; Issues related to Medicare Part D pricing reform.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 26450, "prefix": null, "prefix_display": null, "first_name": "JONATHON", "nickname": null, "middle_name": null, "last_name": "JONES", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 47178, "prefix": null, "prefix_display": null, "first_name": "JOHN", "nickname": null, "middle_name": "MICHAEL", "last_name": "GONZALEZ", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US 31587           0 0         110000.0  

Links from other tables